Trial
NCT06973109
Romosozumab Effects on Bone Density, Muscle Mass, and Spine Surgery Outcomes
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of Pittsburgh
Collaborators
Amgen; Beckwith Foundation
Condition
Osteoporosis, Post-menopausal
Intervention
Romosozumab
Why stopped
Investigator left the institution
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-04